EUCRW Eucrates Biomedical Acquisition Corp. - Warrant

Eucrates Biomedical Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.  This security was issued by Eucrates Biomedical Acquisition Corp. , whose common stock symbol is EUCR.

$0.68  -0.04 (-5.56%)
As of 10/15/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Warrants
Category3:  Shell Companies
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  12/28/2020
Outstanding shares:  3,613,072
Average volume:  856
Market cap:   $131,630,243
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy